Scott Tyldesley, MD  MPA ABR FRCPC

Clinical Professor
University of British Columbia (UBC)

Active Staff – Radiation Oncologist
British Columbia Cancer Agency (BCCA) – Vancouver Centre *

Provincial Breast Outcomes Unit Chair

City: Vancouver
Hospital Authority: Provincial Health Services

Address: BCCA-VCC
600 West 10th Avenue
Vancouver, BC V5Z 4E6

Phone: 604.877.6000 Fax: 604.877.0505


Major Clinical Focus –
• Radiation Oncology and Developmental Radiotherapeutics
• Strategic configuration of cancer care services based on clinical, demographic and geographic considerations

Read a Faculty Spotlight featuring Dr. Scott Tyldesley.

• Master of Public Administration, Queen’s University, Canada, 2000
• Doctor of Medicine, University of British Columbia, Canada, 1993

• Diplomat of the American Board of Radiology in Radiation Oncology, United Stated, 1998
• Fellow of The Royal College of Physicians of Canada, The Royal College of Physicians and Surgeon of Canada, 1998
• Chief Resident (Radiation Oncology), British Columbia Cancer Agency, Vancouver, British Columbia, Canada, 1997-1998
• Resident (Radiation Oncology), British Columbia Cancer Agency, Vancouver, British Columbia, Canada, 1994 – 1997
• Rotating Internship, Greater Victoria Hospital, Victoria, British Columbia, 1993 -1994

Biographic Summary ( Background, Academic Interests and Activities, Clinical Activities )
Dr. Tyldesley is a Radiation Oncologist practicing at the BC Cancer Agency and Clinical Associate Professor in Radiation Oncology at UBC. His areas of expertise include radiation oncology (genitourinary, breast); health policy, health services research and needs assessment. He is a Michael Smith Foundation Scholar in health services research. Dr. Tyldesley is a Co- principal investigator on the Canadian Institute of Health Research funded team for Operations Research in Cancer Care, which is a collaboration between clinicians and administrators at the BC Cancer Agency and operations research scientists at the Sauder School of Business at UBC. He is also the chair of the BC Cancer Agency’s Breast Outcomes Unit. He has over 10 years of clinical experience in the management of breast and genitourinary malignancies.


1. Aristizabal R, Chow VS, French J, Khurshed F, McGahan CE, Puterman ML, Runzer N, Santibáñez P, Tyldesley S., Patient satisfaction after the redesign of a chemotherapy booking process. Healthc Q. 2012;15(3):58-64. (PMID: 22986568)
2. Vinod SK, Wai E, Alexander C, Tyldesley S, Murray N. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada. J Thorac Oncol. 2012 Jul;7(7):1155-63. (PMID: 22617240)
3. Olson RA, Lengoc S, Tyldesley S, French J, McGahan C, Soo J. Relationships between family physicians’ referral for palliative radiotherapy, knowledge of radiotherapy, and prior training: a survey of rural and urban family physicians. Radiat Oncol. 2012 May 18;7(1):73. (PMID: 22607650)
4. Pickles T, Hamm J, Morris WJ, Schreiber WE, Tyldesley S., Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter? BJU Int. 2012 May 7. doi: 10.1111/j.1464-410X.2012.11190.x (PMID: 22564197)
5. Tyldesley S, Peacock M, Morris JW, So A, Kim-Sing C, Quirt J, Carter M, Pickles T. The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British Columbia. Can Urol Assoc J. 2012 Apr;6(2):89-94. doi: 10.5489/cuaj.11158 (PMID: 22511413)
6. Fong A, Shafiq J, Saunders C, Thompson AM, Tyldesley S, Olivotto IA, Barton MB, Dewar JA, Jacob S, Ng W, Speers C, Delaney GP. A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy. Breast. 2012 Aug;21(4):570-7. Epub 2012 Mar 16. (PMID: 22425535)
7. Olson RA, Woods R, Speers C, Lau J, Lo A, Truong PT, Tyldesley S, Olivotto IA, Weir L., Does the intent to irradiate the internal mammary nodes impact survival in women with breast cancer? A population-based analysis in British Columbia. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e35-41. Epub 2012 Feb 16. (PMID: 22342092)
8. Olson RA, Nichol A, Caron NR, Olivotto IA, Speers C, Chia S, Davidson A, Coldman A, Bajdik C, Tyldesley S. Effect of community population size on breast cancer screening, stage distribution, treatment use and outcomes Can J Public Health. 2012 Jan-Feb;103(1):46-52 (PMID: 22338328)
9. AlDuhaiby EZ, Breen S, Bissonnette JP, Sharpe M, Mayhew L, Tyldesley S, Wilke DR, Hodgson DC., A national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in Canada. Radiat Oncol. 2012 Feb 7;7:18 (PMID: 22309806)
10. Fong A, Shafiq J, Saunders C, Thompson A, Tyldesley S, Olivotto IA, Barton MB, Dewar JA, Jacob S, Ng W, Speers C, Delaney GP., A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy. Breast. 2012 Aug;21(4):562-9. Epub 2012 Jan 31 (PMID: 22297168)

* The British Columbia Cancer Agency (BCCA)-Vancouver Centre (VC) is the largest academic cancer centre for the BCCA, located in downtown Vancouver and treating about one third of the radiation oncology cancer patients in the Province of BC. Over 4360 cancer patients are seen each year in the radiation oncology department. There are 20 Radiation Oncology (RO) physician faculty with full disease site specialization and clinical programs of excellence, 2 General Practice (Internist) Oncology Physicians, 3 Clinical Fellows and 10 RO residents. The BCCA-Vancouver Centre also has 17 physicists and a graduate training program in physics, 15 nurses, >60 radiation therapists clerks, secretaries and many others within radiation oncology. General capabilities include 9 Linacs (including Truebeam), 1 cobalt, VMAT (first developed in the BCCA-VC), IMRT, SBRT, IGRT, HDR and LDR brachytherapy suites, and Protons (at the TRIUMF centre). The Vancouver Centre radiation oncology department conducts all levels of research (basic, translational, clinical, population), and is the main educational institution in BC for the training of graduate (residents) and undergraduate (medical) students. The interdisciplinary Radiation Oncology team is part of the even larger multidisciplinary and provincial teams.